From: Clinical observations on infliximab treatment of infantile onset Takayasu arteritis
Treatment | Period | Laboratory tests | ||||
---|---|---|---|---|---|---|
WBC (⋅109/L) | HGB (g/L) | PLT (⋅109/L) | CRP (mg/L) | ESR (mm/1 h) | ||
IFX | Before | 19.31 ± 3.22 (17.56,22.6) | 95.8 ± 11.26 (92,99) | 828.6 ± 192.94 (692,870) | 66.8 ± 39.32 (41,106) | 79 ± 40.51 (58,119) |
After 2 weeks | 14.53 ± 1.82 (13.38,16,59) | 111.8 ± 7.53* (107,120) | 441.6 ± 151.15 (384,641) | 3.66 ± 2.36 (2.3,5) | 17.6 ± 13.15 (7,23) | |
t value | 2.89 | 2.64 | 3.53 | 3.58 | 3.22 | |
p | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
the last time follow-up | 9.76 ± 2.46 (9.09,10.89) | 123 ± 8.66 (120,124) | 366.6 ± 104.11 (304,359) | 3.66 ± 2.36 (0.78,1.9) | 5.2 ± 2.86 (3,7) | |
IFX + GC | Before | 16.07 ± 5.52 (14.38,17.9) | 93.4 ± 6.62 (92,98) | 664.4 ± 193.16 (516,855) | 101.96 ± 33.71 (85,118) | 67.8 ± 40.88 (34,80) |
After 2 weeks | 10.77 ± 4.49 (8.63,12.33) | 119.2 ± 13.95* (108,127) | 386 ± 91.59 (359,472) | 14.88 ± 11.33 (12,17) | 21.2 ± 13.97 (16,29) | |
t value | 1.67 | 3.74 | 7.5 | 5.48 | 2.41 | |
p | 0.13 | 0.01 | 0.01 | 0.01 | 0.04 | |
the last time follow-up | 9.38 ± 1.71 (8.43,10.75) | 123.2 ± 6.97 (118,128) | 329.4 ± 59.23 (298,348) | 2.52 ± 1.00 (2,3.4) | 5.2 ± 3.37 (3,6) |